SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-03-001586
Filing Date
2003-10-30
Accepted
2003-10-30 20:09:54
Documents
1
Period of Report
2002-12-04

Document Format Files

Seq Description Document Type Size
1 srzdurusglfd2_ex.html 4  
1 srzdurusglfd2_ex.xml 4 3408
  Complete submission text file 0000902664-03-001586.txt   5025
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 20 MARSHALL ST STE 320 SOUTH NORWALK CT 06854 2038993100
DURUS LIFE SCIENCES MASTER FUND LTD (Reporting) CIK: 0001257242 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23736 | Film No.: 03968006